"Beclomethasone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA.
Descriptor ID |
D001507
|
MeSH Number(s) |
D04.210.500.745.432.769.125 D04.210.500.883.154
|
Concept/Terms |
Beconase- Beconase
- Becloforte
- Becodisk
- Becodisks
- Propaderm
- Becotide
- Sanasthmyl
Qvar- Qvar
- Ecobec
- Beclazone
- Beclazone Easy Breathe
- Ventolair
- Prolair
- Filair
- Filair Forte
- AeroBec Forte
- Aerobec
- Nasobec Aqueous
- Respocort
|
Below are MeSH descriptors whose meaning is more general than "Beclomethasone".
Below are MeSH descriptors whose meaning is more specific than "Beclomethasone".
This graph shows the total number of publications written about "Beclomethasone" by people in this website by year, and whether "Beclomethasone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Beclomethasone" by people in Profiles.
-
Israel E, Cardet JC, Carroll JK, Fuhlbrigge AL, She L, Rockhold FW, Maher NE, Fagan M, Forth VE, Yawn BP, Arias Hernandez P, Kruse JM, Manning BK, Rodriguez-Louis J, Shields JB, Ericson B, Colon-Moya AD, Madison S, Coyne-Beasley T, Hammer GM, Kaplan BM, Rand CS, Robles J, Thompson O, Wechsler ME, Wisnivesky JP, McKee MD, Jariwala SP, Jerschow E, Busse PJ, Kaelber DC, Nazario S, Hernandez ML, Apter AJ, Chang KL, Pinto-Plata V, Stranges PM, Hurley LP, Trevor J, Casale TB, Chupp G, Riley IL, Shenoy K, Pasarica M, Calderon-Candelario RA, Tapp H, Baydur A, Pace WD. Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma. N Engl J Med. 2022 04 21; 386(16):1505-1518.
-
Skoner DP, Rachelefsky GS, Meltzer EO, Chervinsky P, Morris RM, Seltzer JM, Storms WW, Wood RA. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics. 2000 Feb; 105(2):E23.
-
Ware JE, Kemp JP, Buchner DA, Singer AE, Nolop KB, Goss TF. The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults. Qual Life Res. 1998 Apr; 7(3):235-44.
-
Prenner BM, Chervinsky P, Hampel FC, Howland WC, Lawrence M, Meltzer EO, Munk ZM, Ratner PH, Seltzer JM, Settipane GA, Lorber RR, Harrison JE. Double-strength beclomethasone dipropionate (84 micrograms/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1996 Aug; 98(2):302-8.
-
van As A, Bronsky EA, Dockhorn RJ, Grossman J, Lumry W, Meltzer EO, Seltzer JM, Rogenes PR. Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate. J Allergy Clin Immunol. 1993 Jun; 91(6):1146-54.